Click here to see our COVID19 protocols
Paragon Eye Associates previously known as Ford Eye Center is the LASIK surgery clinic of choice in Arlington and Mansfield, Texas. LASIK, which stands for laser-assisted in-situ keratomileusis, is a procedure that uses non-thermal light to make minor adjustments to the shape of the cornea to correct nearsightedness, farsightedness, and astigmatism.
While all surgical procedures are accompanied by inherent risk, LASIK is FDA-approved and safe with few or no side effects. Minor complications like dry eye occur in less than 5% of patients, while more serious complications like a decline in vision occur in less than 1% of patients.
Because patients can see clearly after the surgery, most surgeons perform LASIK on both eyes at the same time. This creates convenience for patients and eliminates downtime.
Patients lie back in a chair, and the eyes are numbed using anesthetic eye drops. Speculums are placed under the eyelids to hold the eyes wide open for the procedure. A corneal flap is created through a shallow incision, and then the flap is pulled back to reveal deeper layers of the cornea. The non-thermal laser is positioned over the cornea and emits pulses of light to reshape the cornea and correct vision. The flap is then put back into place, where it naturally adheres to the deeper layer of the cornea.
Only an ophthalmologist can determine whether a patient is eligible for LASIK surgery, but in most cases, patients are eligible if they meet the following criteria:
The first step in determining eligibility for LASIK surgery is to schedule a consultation with the professionals at Paragon Eye Associates.
Patients can see more clearly immediately following the procedure and can return to work and begin driving again the very next day.
Very few potential side effects are associated with the LASIK procedure. Some patients may see a “halo” around a light in the dark, while other patients may notice that their eyes are dry after surgery. Both of these side effects resolve over time. In very few cases – less than 1% - the patient’s vision worsens instead of improves and re-treatment is required.